Journal of Neuro-Oncology

, Volume 97, Issue 1, pp 143–148 | Cite as

Report on mutation in exon 15 of the APC gene in a case of brain metastasis

  • Nives Pećina-Šlaus
  • Željka Majić
  • Vesna Musani
  • Martina Zeljko
  • Hrvoje Čupić
Case Report


The study analyzes exon 15 of the adenomatous polyposis coli gene (APC) in a 49-year-old male patient with brain metastasis. The primary site was lung carcinoma. PCR method and direct DNA sequencing of the metastasis and autologous lymphocyte samples identified the presence of a somatic mutation. The substitution was at position 5883 G–A in the metastasis tissue. The mutation was confirmed by RFLP analysis using Msp I endonuclease, since the mutation strikes the Msp I restriction site. Immunohistochemical analysis revealed the lack of protein expression of this tumor suppressor gene. The main molecular activator of the wnt pathway, beta-catenin, was expressed, and located in the nucleus. The mutation is a silent mutation that might have consequences in the creation of a new splice site. Different single-base substitutions in APC exons need not only be evaluated by the predicted change in amino acid sequence, but rather at the nucleotide level itself. In our opinion, such silent mutations should also be incorporated in mutation detection rate and validation.


Adenomatous polyposis coli gene Mutation Brain metastasis G–A transversion 


  1. 1.
    Aretz S, Uhlhaas S, Sun Y, Pagenstecher C, Mangold E, Caspari R, Möslein G, Schulmann K, Propping P, Friedl W (2004) Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene. Hum Mutat 24:370–380CrossRefPubMedGoogle Scholar
  2. 2.
    Joslyn G, Carlson M, Thliveris A, Albertsen H, Gelbert L, Samowitz W, Groden J, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M, White R (1991) Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66:601–613CrossRefPubMedGoogle Scholar
  3. 3.
    Fearnhead NS, Britton MP, Bodmer WF (2001) The ABC of APC. Hum Mol Genet 10:721–733CrossRefPubMedGoogle Scholar
  4. 4.
    Caricasole A, Bakker A, Copani A, Nicoletti F, Gaviraghi G, Terstappen GC (2005) Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology. Biosci Rep 25:309–327CrossRefPubMedGoogle Scholar
  5. 5.
    Gordon MD, Nusse R (2006) Wnt signalling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429–22433CrossRefPubMedGoogle Scholar
  6. 6.
    Scott RJ, van der Luijt R, Spycher M, Mary J-L, Müller A, Hoppeler Th, Haner M, Müller H, Martinoli S, Brazzola P-L, Meera Khan P (1995) Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes. Gut 36:731–736CrossRefPubMedGoogle Scholar
  7. 7.
    Aretz S, Uhlhaas S, Caspari R, Mangold E, Pagenstecher C, Propping P, Friedl W (2004) Frequency and parental origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet 12:52–58CrossRefPubMedGoogle Scholar
  8. 8.
    Nilbert M, Kristoffersson U, Ericsson M, Johannsson O, Rambech E, Mangell P (2008) Broad phenotypic spectrum in familial adenomatous polyposis; from early onset and severe phenotypes to late onset of attenuated polyposis with the first manifestation at age 72. BMC Med Genet 9:101. doi:10.1186/1471-2350-9-101 CrossRefPubMedGoogle Scholar
  9. 9.
    Groves C, Lamlum H, Crabtree M, Williamson J, Taylor C, Bass S, Cuthbert-Heavens D, Hodgson S, Phillips R, Tomlinson I (2002) Mutation cluster region, association between germline and somatic mutations and genotype–phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am J Pathol 160:2055–2061PubMedGoogle Scholar
  10. 10.
    Furuuchi K, Tada M, Yamada H, Kataoka A, Furuuchi N, Hamada J, Takahashi M, Todo S, Moriuchi T (2000) Somatic mutations of the APC gene in primary breast cancers. Am J Pathol 156:1997–2005PubMedGoogle Scholar
  11. 11.
    Nikuševa Martić T, Beroš V, Pećina-Šlaus N, Pećina HI, Bulić-Jakuš F (2007) Genetic changes of CDH1, APC and CTNNB1 found in human brain tumors. Pathol Res Pract 203:779–787CrossRefPubMedGoogle Scholar
  12. 12.
    Pećina-Šlaus N, Beroš V, Nikuševa Martić T, Bulić-Jakuš F (2007) Genomic instability of the APC gene found in glioblastoma. In: Glascow EJ (ed) New research on genomic instability. Novascience, New York, pp 121–137Google Scholar
  13. 13.
    Pećina-Šlaus N, Nikuševa Martić T, Tomas D, Beroš V, Zeljko M, Čupić H (2008) Meningiomas exhibit loss of heterozygosity of the APC gene. J Neurooncol 87:63–70CrossRefPubMedGoogle Scholar
  14. 14.
    D’Amico D, Carbone DP, Johnson BE, Meltzer SJ, Minna JD (1992) Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res 52:1996–1999PubMedGoogle Scholar
  15. 15.
    Cooper CA, Bubb VJ, Smithson N, Carter RL, Gledhill S, Lamb D, Wyllie AH, Carey FA (1996) Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of APC mutation. J Pathol 180:33–37CrossRefPubMedGoogle Scholar
  16. 16.
    Ohgaki H, Kros JM, Okamoto Y, Gaspert A, Huang H, Kurrer MO (2004) APC mutations are infrequent but present in human lung cancer. Cancer Lett 207:197–203CrossRefPubMedGoogle Scholar
  17. 17.
    Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K et al (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455:1069–1075CrossRefPubMedGoogle Scholar
  18. 18.
    Pećina-Šlaus N (1998) Tumor-supresorski geni s posebnim osvrtom na tumor-supresorski gen APC. Liječ Vjesn 120:219–227PubMedGoogle Scholar
  19. 19.
    Heinimann K, Thompson A, Locher A, Furlanetto T, Bader E, Wolf A, Meier R, Walter K, Bauerfeind P, Marra G, Müller H, Foernzler D, Dobbie Z (2001) Nontruncating APC germ-line mutations and mismatch repair deficiency play a minor role in APC mutation-negative polyposis. Cancer Res 61:7616–7622PubMedGoogle Scholar
  20. 20.
    Montera M, Piaggio F, Marchese C, Gismondi V, Stella A, Resta N, Varesco L, Guanti G, Mareni C (2001) A silent mutation in exon 14 of the APC gene is associated with exon skipping in a FAP family. J Med Genet 38:863–867CrossRefPubMedGoogle Scholar
  21. 21.
    Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Rev Genet 3:285–298CrossRefPubMedGoogle Scholar
  22. 22.
    Nystrom-Lahti M, Holmberg M, Fildalgo P, Salovaaro R, de la Chapelle A, Jiricny J, Peltomaki P (1999) Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds. Genes Chrom Cancer 26:372–375CrossRefPubMedGoogle Scholar
  23. 23.
    Liu W, Qian C, Francke U (1997) Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat Genet 16:328–329CrossRefPubMedGoogle Scholar
  24. 24.
    Chao HK, Hsiao KJ, Su TS (2001) A silent mutation induces exon skipping in the phenylalaninehydroxylase gene in phenylketonuria. Hum Genet 108:14–19CrossRefPubMedGoogle Scholar
  25. 25.
    Kartheuser A, Walon C, West S, Breukel C, Detry R, Gribomont AC, Hamzehloei T, Hoang P, Maiter D, Pringot J, Rahier J, Meera Khan P, Curtis A, Burn J, Fodde R, Verellen-Dumoulin C (1999) Familial adenomatous polyposis associated with multiple adrenal adenomas in a patient with a rare 3′ APC mutation. J Med Genet 36:65–67PubMedGoogle Scholar
  26. 26.
    van der Luijt RB, Meera Khan P, Vasen HFA, Breukel C, Tops CMJ, Scott RJ, Fodde R (1996) Germline mutations in the 3′ part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum Genet 98:727–734CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2009

Authors and Affiliations

  • Nives Pećina-Šlaus
    • 1
    • 2
  • Željka Majić
    • 1
  • Vesna Musani
    • 3
  • Martina Zeljko
    • 1
  • Hrvoje Čupić
    • 4
  1. 1.Laboratory of NeurooncologyCroatian Institute for Brain Research, School of Medicine University of ZagrebZagrebCroatia
  2. 2.Department of BiologySchool of Medicine University of ZagrebZagrebCroatia
  3. 3.Division of Molecular MedicineLaboratory for Hereditary Cancer, Ruđer Bošković InstituteZagrebCroatia
  4. 4.Ljudevit Jurak Department of PathologyUniversity Hospital “Sisters of Charity”ZagrebCroatia

Personalised recommendations